Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
144.70
+3.50 (2.48%)
Jun 6, 2025, 4:00 PM - Market closed
CRL Employees
Charles River Laboratories International had 20,100 employees as of December 31, 2024. The number of employees decreased by 1,700 or -7.80% compared to the previous year.
Employees
20,100
Change (1Y)
-1,700
Growth (1Y)
-7.80%
Revenue / Employee
$200,129
Profits / Employee
-$1,570
Market Cap
7.11B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20,100 | -1,700 | -7.80% |
Dec 31, 2023 | 21,800 | 400 | 1.87% |
Dec 31, 2022 | 21,400 | 1,400 | 7.00% |
Dec 25, 2021 | 20,000 | 1,600 | 8.70% |
Dec 26, 2020 | 18,400 | 1,300 | 7.60% |
Dec 28, 2019 | 17,100 | 2,400 | 16.33% |
Dec 29, 2018 | 14,700 | 2,900 | 24.58% |
Dec 30, 2017 | 11,800 | 800 | 7.27% |
Dec 31, 2016 | 11,000 | 2,400 | 27.91% |
Dec 26, 2015 | 8,600 | 700 | 8.86% |
Dec 27, 2014 | 7,900 | 200 | 2.60% |
Dec 28, 2013 | 7,700 | 500 | 6.94% |
Dec 29, 2012 | 7,200 | 100 | 1.41% |
Dec 31, 2011 | 7,100 | -400 | -5.33% |
Dec 25, 2010 | 7,500 | -500 | -6.25% |
Dec 26, 2009 | 8,000 | -1,000 | -11.11% |
Dec 27, 2008 | 9,000 | 500 | 5.88% |
Dec 29, 2007 | 8,500 | 500 | 6.25% |
Dec 30, 2006 | 8,000 | -400 | -4.76% |
Dec 31, 2005 | 8,400 | 400 | 5.00% |
Dec 25, 2004 | 8,000 | 3,500 | 77.78% |
Dec 27, 2003 | 4,500 | -500 | -10.00% |
Dec 28, 2002 | 5,000 | 1,000 | 25.00% |
Dec 29, 2001 | 4,000 | 500 | 14.29% |
Dec 30, 2000 | 3,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CRL News
- 4 days ago - Charles River Laboratories to Present at William Blair and Jefferies Conferences - Business Wire
- 9 days ago - Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington's Disease Research - Business Wire
- 24 days ago - Charles River Laboratories to Present at Bank of America Health Care Conference - Business Wire
- 27 days ago - Activist Elliott reaches key agreement with Charles River. Here are three ways to create value - CNBC
- 4 weeks ago - S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments - Investopedia
- 4 weeks ago - Charles River Laboratories International, Inc. (CRL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On Signs Of Demand Stabilization - Benzinga
- 4 weeks ago - Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help. - Barrons